Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Mitarbeiter des Rudolf-Boehm-Institutes
Vorlage Geschäftsbrief mit Siegel
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Inhalt. Transparenz. Forschen Lehren Heilen. Struktur & Prozess Menschen. Wichtige Kennzahlen Leistungsdaten. Einrichtungen & Ansprechpartner - PDF Free Download
Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Focused Ultrasound Therapy
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's D
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE
European Technology Platform on Nanomedicine
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Zeitschrift für Naturforschung C
Type of the Paper (Article
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Mitarbeiter des Rudolf-Boehm-Institutes
Loop | Achim Aigner
SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library
